Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajeshwar P Mookerjee

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Gut|December 24, 2018
Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacityHannelie Korf, Johannie du Plessis, Jos van Pelt, et al.
Journal of Hepatology|September 8, 2020
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope ConsortiumElsa Solà, Elisa Pose, Daniela Campion, et al.
The Lancet. Gastroenterology & Hepatology|October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trialElisa Pose, Laura Napoleone, Ahmed Amin, et al.
Hepatology Communications|December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated CirrhosisElisa Pose, Elsa Solà, Juan J Lozano, et al.
Gastroenterology|January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitisJosé Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Frontiers in Immunology|April 4, 2019
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated CirrhosisJonel Trebicka, Alex Amoros, Carla Pitarch, et al.
Journal of Hepatology|June 2, 2023
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failureBanwari Agarwal, Rafael Bañares Cañizares, Faouzi Saliba, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
Gut|April 15, 2024
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosisJinxia Liu, Jane MacNaughtan, Annarein J C Kerbert, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Gut|December 24, 2018
Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacityHannelie Korf, Johannie du Plessis, Jos van Pelt, et al.
Journal of Hepatology|September 8, 2020
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope ConsortiumElsa Solà, Elisa Pose, Daniela Campion, et al.
The Lancet. Gastroenterology & Hepatology|October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trialElisa Pose, Laura Napoleone, Ahmed Amin, et al.
Hepatology Communications|December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated CirrhosisElisa Pose, Elsa Solà, Juan J Lozano, et al.
Gastroenterology|January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitisJosé Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Frontiers in Immunology|April 4, 2019
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated CirrhosisJonel Trebicka, Alex Amoros, Carla Pitarch, et al.
Journal of Hepatology|June 2, 2023
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failureBanwari Agarwal, Rafael Bañares Cañizares, Faouzi Saliba, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
Gut|April 15, 2024
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosisJinxia Liu, Jane MacNaughtan, Annarein J C Kerbert, et al.
Pageof 12